Citadel Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-547,822
| Closed | -$62K | – | 10277 |
|
|
2018
Q4 | $62K | Buy |
547,822
+510,182
| +1,355% | +$335K | ﹤0.01% | 8432 |
|
|
2018
Q3 | $64K | Buy |
+37,640
| New | +$67.4K | ﹤0.01% | 8747 |
|
|
2018
Q1 | – | Sell |
-263,448
| Closed | -$556K | – | 9101 |
|
|
2017
Q4 | $587K | Sell |
263,448
-5,863,884
| -96% | -$14.6M | ﹤0.01% | 5404 |
|
|
2017
Q3 | $17.8M | Buy |
6,127,332
+123,663
| +2% | +$422K | 0.01% | 1149 |
|
|
2017
Q2 | $26.7M | Buy |
6,003,669
+94,203
| +2% | +$388K | 0.02% | 818 |
|
|
2017
Q1 | $27.5M | Buy |
5,909,466
+5,321,541
| +905% | +$30.9M | 0.03% | 761 |
|
|
2016
Q4 | $3.58M | Sell |
587,925
-1,203,170
| -67% | -$6.29M | ﹤0.01% | 2323 |
|
|
2016
Q3 | $9.87M | Buy |
1,791,095
+98,658
| +6% | +$462K | 0.01% | 1368 |
|
|
2016
Q2 | $6.43M | Buy |
1,692,437
+1,139,087
| +206% | +$3.86M | 0.01% | 1616 |
|
|
2016
Q1 | $1.53M | Sell |
553,350
-1,940,620
| -78% | -$7.03M | ﹤0.01% | 2960 |
|
|
2015
Q4 | $14.1M | Sell |
2,493,970
-1,420,685
| -36% | -$8.66M | 0.02% | 1043 |
|
|
2015
Q3 | $20.7M | Buy |
3,914,655
+3,327,408
| +567% | +$25.8M | 0.02% | 881 |
|
|
2015
Q2 | $4.87M | Buy |
587,247
+538,674
| +1,109% | +$2.61M | ﹤0.01% | 2091 |
|
|
2015
Q1 | $224K | Buy |
48,573
+16,068
| +49% | +$52.3K | ﹤0.01% | 6050 |
|
|
2014
Q4 | $99K | Buy |
32,505
+13,447
| +71% | +$39.8K | ﹤0.01% | 6641 |
|
|
2014
Q3 | $53K | Buy |
19,058
+9,670
| +103% | +$35.1K | ﹤0.01% | 6872 |
|
|
2014
Q2 | $38K | Sell |
9,388
-29,369
| -76% | -$125K | ﹤0.01% | 6937 |
|
|
2014
Q1 | $206K | Buy |
+38,757
| New | +$217K | ﹤0.01% | 5480 |
|
Other funds holding SGYP
Citadel Advisors's SGYP Position: Q1 2019 in Review
Citadel Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 547,822 shares — an estimated $62K sold.
Citadel Advisors first reported a position in SGYP in Q1 2014 and held it in 18 quarters. The position peaked at $27.5M in Q1 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Citadel Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Citadel Advisors sold 547,822 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $62K.
- Citadel Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2014 and held it in 18 quarters.
- Citadel Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $27.5M in Q1 2017.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.